158 related articles for article (PubMed ID: 10392173)
21. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
[TBL] [Abstract][Full Text] [Related]
22. Bolus injection (2-4 min) versus short-term (10-20 min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial. Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
Glimelius B; Jakobsen A; Graf W; Berglund A; Gadeberg C; Hansen P; Kjaer M; Brunsgaard N; Sandberg E; Lindberg B; Sellström H; Lorentz T; Påhlman L; Gustavsson B
Eur J Cancer; 1998 Apr; 34(5):674-8. PubMed ID: 9713273
[TBL] [Abstract][Full Text] [Related]
23. High-dose infusional 5-FU in the treatment of advanced colorectal cancer: a summary of the European experience.
Wils JA
J Infus Chemother; 1996; 6(3):145-8. PubMed ID: 9229327
[TBL] [Abstract][Full Text] [Related]
24. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer.
Hansen RM; Ryan L; Anderson T; Krzywda B; Quebbeman E; Benson A; Haller DG; Tormey DC
J Natl Cancer Inst; 1996 May; 88(10):668-74. PubMed ID: 8627643
[TBL] [Abstract][Full Text] [Related]
25. Capecitabine versus continuous-infusion 5-fluorouracil for colorectal cancer: a retrospective efficacy and safety comparison.
Saif MW
Clin Colorectal Cancer; 2005 Jul; 5(2):89-100. PubMed ID: 16098249
[TBL] [Abstract][Full Text] [Related]
26. No circadian variation of dihydropyrimidine dehydrogenase, uridine phosphorylase, beta-alanine, and 5-fluorouracil during continuous infusion of 5-fluorouracil.
Van Kuilenburg AB; Poorter RL; Peters GJ; Van Gennip AH; Van Lenthe H; Stroomer AE; Smid K; Noordhuis P; Bakker PJ; Veenhof CH
Adv Exp Med Biol; 1998; 431():811-6. PubMed ID: 9598176
[No Abstract] [Full Text] [Related]
27. Contribution of meta-analyses to the evaluation of treatments for advanced colorectal cancer.
Zelek L; Piedbois P; Buyse M
Expert Rev Anticancer Ther; 2002 Aug; 2(4):417-25. PubMed ID: 12647985
[TBL] [Abstract][Full Text] [Related]
28. Variability in administration of 5-fluorouracil and folinic acid in standard treatment regimens for advanced colorectal cancer.
Zalcberg JR; Harsley SR; Dooley MJ
Intern Med J; 2002 Dec; 32(12):610-3. PubMed ID: 12512755
[No Abstract] [Full Text] [Related]
29. A multicenter randomized study comparing 5-fluorouracil continuous infusion (ci) plus 1-hexylcarbamoyl-5-fluorouracil and 5-FU ci alone in colorectal cancer.
Kotake K; Ohashi Y; Kodaira S; Koyama Y;
Oncol Rep; 2005 Jul; 14(1):129-34. PubMed ID: 15944779
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle.
Tejpar S; Saridaki Z; Delorenzi M; Bosman F; Roth AD
J Natl Cancer Inst; 2011 Jun; 103(11):841-4. PubMed ID: 21597023
[No Abstract] [Full Text] [Related]
31. [Continuous intravenous infusional 5-FU compared with bolus administration in metastatic colorectal carcinoma].
Dunst J
Strahlenther Onkol; 1998 Sep; 174(9):489-90. PubMed ID: 9765695
[No Abstract] [Full Text] [Related]
32. 5-fluorouracil alone versus 5-fluorouracil plus folinic acid in the treatment of colorectal carcinoma: meta-analysis.
Lo Bello L; Pistone G; Restuccia S; Vinci E; Mazzoleni G; Malaguarnera M
Int J Clin Pharmacol Ther; 2000 Dec; 38(12):553-62. PubMed ID: 11125868
[TBL] [Abstract][Full Text] [Related]
33. 5-fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancer.
Jodrell DI; Stewart M; Aird R; Knowles G; Bowman A; Wall L; McLean C
Br J Cancer; 2001 Mar; 84(5):600-3. PubMed ID: 11237378
[TBL] [Abstract][Full Text] [Related]
34. Different intravenous administration techniques for 5-fluorouracil. Pharmacokinetics and pharmacodynamic effects.
Larsson PA; Carlsson G; Gustavsson B; Graf W; Glimelius B
Acta Oncol; 1996; 35(2):207-12. PubMed ID: 8639317
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience.
Comella P; Massidda B; Natale D; Putzu C; Sandomenico C; Filippelli G; Palmeri S; Condemi G; Vessia G; Barberis G; Ionta MT; Tafuto S; Barbato E
Clin Colorectal Cancer; 2011 Mar; 10(1):42-7. PubMed ID: 21609935
[TBL] [Abstract][Full Text] [Related]
36. Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation.
Sobrero AF; Aschele C; Bertino JR
J Clin Oncol; 1997 Jan; 15(1):368-81. PubMed ID: 8996164
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer.
Cure H; Chevalier V; Pezet D; Bousquet J; Focan C; Levi F; Garufi C; Chipponi J; Chollet P
Anticancer Res; 2000; 20(6C):4649-53. PubMed ID: 11205195
[TBL] [Abstract][Full Text] [Related]
38. [Intravenous continuous infusion of fluorouracil for treatment of metastatic colorectal cancer].
Hosokawa A
Nihon Rinsho; 2003 Sep; 61 Suppl 7():352-5. PubMed ID: 14574911
[No Abstract] [Full Text] [Related]
39. A phase I-II trial of five-day continuous intravenous infusion of 5-fluorouracil delivered at circadian rhythm modulated rate in patients with metastatic colorectal cancer.
Lévi F; Soussan A; Adam R; Caussanel JP; Metzger G; Jasmin C; Bismuth H; Smolensky M; Misset JL
J Infus Chemother; 1995; 5(3 Suppl 1):153-8. PubMed ID: 8528977
[TBL] [Abstract][Full Text] [Related]
40. Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen.
Ychou M; Duffour J; Kramar A; Debrigode C; Gourgou S; Bressolle F; Pinguet F
Cancer Chemother Pharmacol; 2003 Oct; 52(4):282-90. PubMed ID: 12827293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
